Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$21.2M
-68.2% from 2023
Prescriptions
134K
$158.03 per claim
Patients
36K
28,838 prescribers
Total spending, 2024
$21.2M
$591.62 per patient
Medicare prescription drug plans paid $21.2M for Novolin 70-30 Flexpen in 2024, for 134,109 prescriptions and refills to 35,824 patients (down 68.2% from 2023). The average cost per claim was $158.03.
Florida had the highest Medicare cost for Novolin 70-30 Flexpen in 2024: $3.5M for 23,462 claims, followed by Texas ($1.7M).
Farah R Dawood-Farah, endocrinology in Rochester Hills, MI, had the highest Medicare cost for Novolin 70-30 Flexpen in 2024: 218 claims costing $44K.
Novolin 70-30 Flexpen is made by Novo Nordisk A/S (NVO), listed in the Medicare spending data as Novo Nordisk, Novo Nordisk-Wa.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Farah R Dawood-Farah Rochester Hills, MI | Endocrinology | 218 | 71 | $44K |
| Sumbul A Ali Spring Hill, FL | Endocrinology | 81 | 27 | $32K |
| Daniela M Dicenso |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 24,521 | 115,775 | 28,797 | $56.4M |
| 2023 | 27,120 | 131,686 | 32,302 | $66.6M |
| 2024 | 28,838 | 134,109 | 35,824 | $21.2M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 149 |
| 48 |
| $23K |
| Chih C Chang Sellersburg, IN | Endocrinology | 92 | 28 | $20K |
| Vasdev Lohano Washington, IN | Endocrinology | 89 | 25 | $19K |
| Hemant T Thawani Grand Blanc, MI | Endocrinology | 73 | 30 | $19K |
| Rachel N Shell Bourbonnais, IL | Endocrinology | 54 | 14 | $17K |
| Marina K Russo Springfield, IL | Endocrinology | 48 | 13 | $16K |
| James W Edmondson Indianapolis, IN | Endocrinology | 70 | 17 | $16K |
| Robert P Castellucci Richmond, VA | Endocrinology | 67 | 16 | $15K |
| Olivia A Cassiday Milwaukee, WI | Nurse Practitioner | 73 | 21 | $15K |
| Paule Thomas Lauderdale Lakes, FL | Nurse Practitioner | 110 | 33 | $15K |
| Seema Ahluwalia Chandler, AZ | Endocrinology | 63 | 21 | $15K |
| Amy E Scanlon Deptford, NJ | Nurse Practitioner | 41 | 16 | $15K |
| Megan E Gebhart Menasha, WI | Nurse Practitioner | 58 | 12 | $14K |
| Rodolfo Guzman Bronx, NY | Endocrinology | 94 | 21 | $14K |
| Israel Hodish Roanoke, VA | Endocrinology | 28 | Under 11 | $13K |
| Tamara Lawry Houston, TX | Nurse Practitioner | 121 | 48 | $13K |
| Niral Patel Lauderdale Lakes, FL | Internal Medicine | 103 | 23 | $13K |
| Jabiz Behzadpour Bourbonnais, IL | Endocrinology | 56 | 14 | $13K |
| Enrique J Griego McAllen, TX | Family Practice | 79 | 31 | $13K |
| Adrienne M Serneels Tampa, FL | Family Practice | 86 | 17 | $13K |
| Anne Webster Peoria, IL | Nurse Practitioner | 102 | 18 | $13K |
| Mukesh Jain Southaven, MS | Internal Medicine | 54 | 19 | $13K |
| Paul A Graham Vero Beach, FL | Endocrinology | 87 | 29 | $13K |
Spending by manufacturer as listed in the spending data